Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 2
Emerging therapies and new directions in the treatment of pulmonary arterial hypertension
Grzegorz Kopec, Andris Skride, Egle Ereminiene, Iveta Šimkova, Roxana Enache, Miroslav Samaržija, Barbara Salobir, Pavel Jansa
Pregledni znanstveni članek
Oznake: activin signaling inhibitors;novel therapies;risk assessment;treatment strategy;sotatercept;
Pulmonary arterial hypertension (PAH) is a severe and progressive disease with limited survival prospects under currently available therapies. Since the 2022 edition of the European Society of Cardiology and European Respiratory Society guidelines on pulmonary hypertension, substantial clinical evid ...
Leto: 2025 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Long-term treatment with subcutaneous treprostinil in patients with severe inoperable chronic thromboembolic pulmonary hypertension in the multimodal therapy era (data from CTREPH study open label extension)
Pavel Jansa, Roela Sadushi-Kolici, Nika Skoro-Sajer, Grzegorz Kopec, Iveta Šimkova, Regina Steringer-Mascherbauer, Barbara Salobir
Izvirni znanstveni članek
Oznake: kronična trombembolična pljučna hipertenzija;multimodalno zdravljenje;podkožni treprostinil;chronic thromboembolic pulmonary hypertension;multimodal treatment;subcutaneous treprostinil;
The aim of the open label extension (OLE) of CTREPH study was to characterize multimodal treatment in patients with severe inoperable CTEPH, to describe long-term subcutaneous (SC) treprostinil safety and tolerability, and to evaluate change in functional class and exercise capacity over 24 months s ...
Leto: 2025 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Št. zadetkov: 2
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: